PTCE Pharmacy Connect | Pharmacy Times

Treatment of Duchenne Muscular Dystrophy: Updates in Disease-Modifying Drugs | PTCE Pharmacy Connect


Listen Later

Educational Objectives

  • Recall the pathophysiology and clinical manifestations of Duchenne muscular dystrophy (DMD), as well as the burden of DMD and its impact on patient quality of life
  • List the latest updates for the safety and efficacy data of new and approved disease-modifying therapies in the treatment of DMD
  •  

    Faculty:

    Amanda Hickman, PharmD, MPH, MSCS

    Central Support Pharmacist – Neuro/Psych/Sleep

    Trellis Rx

    Atlanta, Georgia

     

    Moderator:

    Jessica L. Kerr, PharmD, CDCES

    Associate Dean – Office Professional and Student Affairs

    Professor/Clinical Pharmacist

    Southern Illinois University Edwardsville

    School of Pharmacy

    Edwardsville, Illinois

     

    Amanda Hickman, PharmD, MPH, MSCS, and Jessica L. Kerr, PharmD, CDCES, have no financial relationships with commercial interests to disclose.


    Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hours (0.075 CEU) under the ACPE universal activity number 0290-0000-22-613-H01-P. The activity is available for CE credit through December 22, 2023.

     

    This activity is supported by an educational grant from Sarepta Therapeutics.

    ...more
    View all episodesView all episodes
    Download on the App Store

    PTCE Pharmacy Connect | Pharmacy TimesBy Pharmacy Times